UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of innate and adaptive immunity to RSV in young children

Cellular immunology, 2024-05, Vol.399-400, p.104824-104824, Article 104824

2024

Volltextzugriff (PDF)

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Frontiers in immunology, 2024, Vol.15, p.1382318-1382318

2024

Volltextzugriff (PDF)

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Volltextzugriff (PDF)

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

Immunology of bovine respiratory syncytial virus in calves

Molecular immunology, 2015-07, Vol.66 (1), p.48-56

2015

Volltextzugriff (PDF)

Novel antigens for RSV vaccines

Current opinion in immunology, 2015-08, Vol.35, p.30-38

2015

Volltextzugriff (PDF)

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Clinical and vaccine immunology, 2016-03, Vol.23 (3), p.189-195

2016

Volltextzugriff (PDF)

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

The Journal of infectious diseases, 2020-06, Vol.221 (12), p.2050-2059

2020

Volltextzugriff (PDF)

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Immunological reviews, 2011-01, Vol.239 (1), p.149-166

Graham, Barney S.

2011

Volltextzugriff (PDF)

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Vaccine, 2017-02, Vol.35 (5), p.757-766

2017

Volltextzugriff (PDF)

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1360-1368

2024

Volltextzugriff (PDF)

Progress toward a Respiratory Syncytial Virus Vaccine

Clinical and vaccine immunology, 2016-03, Vol.23 (3), p.186-188

2016

Volltextzugriff (PDF)

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

The Journal of infectious diseases, 2017-01, Vol.215 (1), p.24-33

2017

Volltextzugriff (PDF)

Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus

Frontiers in immunology, 2018-03, Vol.9, p.323-323

2018

Volltextzugriff (PDF)

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

The Journal of infectious diseases, 2020-02, Vol.221 (4), p.534-543

2020

Volltextzugriff (PDF)

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Volltextzugriff (PDF)

Passive and active immunization against respiratory syncytial virus for the young and old

Expert review of vaccines, 2017-07, Vol.16 (7), p.737-749

2017

Volltextzugriff (PDF)

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Volltextzugriff (PDF)

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein

Clinical and vaccine immunology, 2016-06, Vol.23 (6), p.451-459

2016

Volltextzugriff (PDF)

The CD4 T cell response to respiratory syncytial virus infection

Immunologic research, 2014-08, Vol.59 (1-3), p.109-117

2014

Volltextzugriff (PDF)

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Volltextzugriff (PDF)

Structure and function of respiratory syncytial virus surface glycoproteins

Current topics in microbiology and immunology, 2013, Vol.372, p.83

2013

Volltextzugriff (PDF)

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

Vaccine, 2024-05, Vol.42 (13), p.3172-3179

2024

Volltextzugriff (PDF)

The Human Immune Response to Respiratory Syncytial Virus Infection

Clinical microbiology reviews, 2017-04, Vol.30 (2), p.481-502

2017

Volltextzugriff (PDF)

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

Frontiers in immunology, 2024-04, Vol.15, p.1377374-1377374

2024

Volltextzugriff (PDF)

1 – 25 von 3.753

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.611)
Mit Volltextzugriff
(2.853)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.645)
Life Sciences & Biomedicine
(3.535)
Respiratory Syncytial Virus
(2.768)
Humans
(2.434)
Infectious Diseases
(1.607)
Female
(1.259)
Microbiology
(1.168)
Infant
(1.132)
Animals
(1.098)
Viruses
(1.063)
Biological And Medical Sciences
(1.017)
Infections
(959)
Male
(937)
Respiratory Syncytial Virus Infections - Immunology
(793)
Medical Sciences
(752)
Pediatrics
(745)
Child, Preschool
(661)
Respiratory Syncytial Viruses - Immunology
(626)
Mice
(625)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(24)

Menü

Weitere Dienste

Einstellungen

Development of innate and adaptive immunity to RSV in young children

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

Immunology of bovine respiratory syncytial virus in calves

Novel antigens for RSV vaccines

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Progress toward a Respiratory Syncytial Virus Vaccine

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Passive and active immunization against respiratory syncytial virus for the young and old

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein

The CD4 T cell response to respiratory syncytial virus infection

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Structure and function of respiratory syncytial virus surface glycoproteins

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

The Human Immune Response to Respiratory Syncytial Virus Infection

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

Aktive Filter

Suchergebnisse filtern